PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22022624-6	2011	Antiviral activity and reduced disease severity was evidenced by dramatic reductions in peak serum virus titers and AST concentrations in favipiravir-treated animals.	favipiravir	138-149	solute carrier family 17 member 5	Homo sapiens	116-119	
34703696-6	2021	AST elevation was found, respectively, as 133 (29.3%), 32 (28.3%) (p=0.100), ALT elevation as 112 (24.7%), 35 (29.3%) (p=0.100) in the groups receiving and not receiving favipiravir.	favipiravir	170-181	solute carrier family 17 member 5	Homo sapiens	0-3